Atai stock forecast.

ATAI Life Sciences N.V. Stock Chart and Share Price Forecast, Short-Term "ATAI" Stock Prediction for Next Days and Weeks Walletinvestor.com ATAI Life Sciences N.V. (ATAI) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024Their CMPS share price targets range from $19.00 to $120.00. On average, they anticipate the company's stock price to reach $46.83 in the next year. This suggests a possible upside of 683.2% from the stock's current price. View analysts price targets for CMPS or view top-rated stocks among Wall Street analysts.According to the issued ratings of 1 analysts in the last year, the consensus rating for Arcadia Biosciences stock is Buy based on the current 1 buy rating for RKDA. The average twelve-month price prediction for Arcadia Biosciences is $15.00 with a high price target of $20.00 and a low price target of $10.00. Learn more on RKDA's analyst …Atari S.A. is an interactive entertainment company and an iconic gaming industry brand that transcends generations and audiences. The company is globally recognized for its multi-platform, interactive entertainment and licensed products.

Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $214.15M. -60.0%. Market Cap / Employee. The market cap of a ...

13. 1. 2023. ... atai Life Sciences Founder Christian Angermayer explains that all will ... Stock Market Sectors You Like 32:39 - 33:42 Optimism For Industry ...SOFI - SoFi Technologies Inc Stock quote - CNNMoney.com

Shares of the Peter Thiel -backed psychedelic start-up Atai Life Sciences jumped Friday on their first day of trading on Wall Street. The newly listed Nasdaq stock opened up 40% before pulling ...ATAI Life Sciences N.V. Stock Chart and Share Price Forecast, Short-Term "ATAI" Stock Prediction for Next Days and Weeks Walletinvestor.com ATAI Life Sciences N.V. (ATAI) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024 ATAI Life Sciences NV Stock Forecast. Is ATAI Life Sciences NV Stock Undervalued? The current ATAI Life Sciences NV [ ATAI] share price is $1.06. The Score for ATAI is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. ATAI is currently trading in the 10-20% percentile range relative to its historical ... Aug 30, 2022 · ATAI stock is down 44% year-to-date (YTD), despite a 10% increase over the past month. Shares are changing hands at 2.4x book value. Wall Street’s 12-month median price forecast for ATAI stock ...

The highest rated platform for investors in the world! TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions. TipRanks stock market research and analysis, lets you see the track record and measured performance of any analyst or blogger, so you know who to trust!

Stock Price Forecast The 6 analysts offering 12-month price forecasts for Ouster Inc have a median target of 9.50, with a high estimate of 12.00 and a low estimate of 6.00.

According to TipRanks, Palomeque has an average return of -14.1% and a 28.57% success rate on recommended stocks. Currently, the analyst consensus on ATAI Life Sciences is a Strong Buy with an average price target of $13.75.See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $4.96 and a one-year low of $1.14. Sep 30, 2023.RPHM. Reneo Pharmaceuticals Inc. 6.04. +0.10. +1.68%. Get ATAI Life Sciences NV (ATAI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.EOSE Stock 12 Months Forecast. $10.50. (845.95% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Eos Energy Enterprises in the last 3 months. The average price target is $10.50 with a high forecast of $17.00 and a low forecast of $2.00. The average price target represents a 845.95% change from the last price of $1.11.3:24 pm. Articles. atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine) August 10, 2023 Advanced multiple clinical stage assets in development, including the on-going Phase 2b study of RL-007 in patients…. August 10, …Stock Price Forecast The 6 analysts offering 12-month price forecasts for Ouster Inc have a median target of 9.50, with a high estimate of 12.00 and a low estimate of 6.00.The total addressable market for AI is massive; by 2030, it's expected to be worth nearly $2 trillion, according to Statista. That's a massive pie, and multiple companies will be vying for these ...Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Super Micro Computer Inc have a median target of 397.00, with a high estimate of 500.00 and a low estimate of 240.00.

Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive impairment associated with ...ATAI Life Sciences N.V. analyst ratings, historical stock prices, earnings estimates & actuals. ATAI updated stock price target summary.43.55. -2.16%. 5.29M. Find the latest ATAI Life Sciences BV (ATAI) stock forecast, 12-month price target, predictions and analyst recommendations.WebATAI Life Sciences N.V. (ATAI) stock forecast and price target. Find the latest ATAI Life Sciences N.V. ATAI analyst stock forecast, price target, and recommendation trends …WebAbout Pre-Market Quotes. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. NVIDIA Corporation Common Stock. ATAI Life Sciences N ...

Jul 28, 2022 · Atai Life Sciences. One of Atai Life Sciences' early investors was venture capitalist Peter Thiel. The company went public in June 2021 at $15 and is currently trading at $3.78 with a market cap ... RPHM. Reneo Pharmaceuticals Inc. 6.04. +0.10. +1.68%. Get ATAI Life Sciences NV (ATAI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

24. 3. 2023. ... ... predictions of future events. Although we believe that the ... Total stockholders' equity attributable to ATAI Life Sciences N.V. stockholders ...Nov 24, 2023 · On Friday 11/24/2023 the closing price of the ATAI Life Sciences N.V. Registered Shs share was $1.10 on NAS. Compared to the opening price on Friday 11/24/2023 on NAS of $1.12, this is a drop of 1 ... Read an investment analysis of ATAI stock here. ... By 2029, it is forecast to be worth $7.2 billion globally, with a compound annual growth rate of 55%. Also, ...WebAre you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.30. 3. 2023. ... Psychedelic Stocks' Promising Outlook For Investors - Psychedelics Exclusive ... atai Founder Reveals 14 Reasons To Remain Optimistic - TDR ...CMPS Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for COMPASS Pathways in the last 3 months. The average price target is $50.17 with a high forecast of $120.00 and a low forecast of $21.00. The average price target represents a 832.53% change from the last price of $5.38.Part of ATAI stock’s negative performance can be attributed to some poor clinical trial results. The company began the year by announcing disappointing news regarding a Phase 2 trial for PCN-101 ...Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Bird Global Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median ...The forecasts range from a low of 5.15 to a high of $23.10. The average price target represents an increase of 605.71% from its latest reported closing price of 1.90. See our leaderboard of ...CMPS Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for COMPASS Pathways in the last 3 months. The average price target is $50.17 with a high forecast of $120.00 and a low forecast of $21.00. The average price target represents a 832.53% change from the last price of $5.38.

Atai Life Sciences has a strong pipeline of drugs for the next 18 months, and will pursue aggressive growth. The company had $335 million in cash as of May 2022, which is roughly 50% of its ...

Company Description. ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive …

2023 Outlook Reports. ... The small-cap market has been invaded by a flurry of psychedelics stocks to watch thanks to new company launches. ... ATAI Life Sciences is a clinical-stage biopharma ...When is Atai Life Sciences's earnings date? Atai Life Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 22nd, 2024 based off last year's report dates. Learn more on ATAI's earnings history.From July 11 to July 13, Wood purchased 947,340 shares of BFLY stock. 5. ATAI Life Sciences (ATAI) ... Stocks to Buy AMZN Stock Forecast: Predicting Amazon’s Performance in 2023 and Beyond30. 3. 2023. ... Psychedelic Stocks' Promising Outlook For Investors - Psychedelics Exclusive ... atai Founder Reveals 14 Reasons To Remain Optimistic - TDR ...Read an investment analysis of ATAI stock here. ... By 2029, it is forecast to be worth $7.2 billion globally, with a compound annual growth rate of 55%. Also, ...Nov 24, 2023 · NeuBase Therapeutics' stock was trading at $3.8040 on January 1st, 2023. Since then, NBSE stock has decreased by 82.2% and is now trading at $0.6758. View the best growth stocks for 2023 here. Are investors shorting NeuBase Therapeutics? NeuBase Therapeutics saw a decrease in short interest in the month of October. Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Somalogic Inc have a median target of 4.75, with a high estimate of 7.00 and a low estimate of 2.30. The median estimate ...Cybin Inc. (OTC: CLXPF) stock has returned more than 3,485% to investors in the past twelve months. The firm operates as a life sciences company concentrating on the development of psychedelic drugs.Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Bird Global Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median ...Company Description. ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive …Find real-time SMCI - Super Micro Computer Inc stock quotes, company profile, news and forecasts from CNN Business.

25. 5. 2023. ... As of May 24, 2023, ATAI Life Sciences boasts an average one-year price target of $13.75, as predicted by industry analysts. These forecasts ...35,390.15 +117.12(+0.33%) Nasdaq -15.00(-0.11%) Russell 2000 1,807.50 +11.96(+0.67%) Crude Oil 75.54 -1.56(-2.02%) Gold 2,003.00 +10.20(+0.51%) Atai Life Sciences N.V. …WebHistorical daily share price chart and data for Atai Life Sciences since 2008 adjusted for splits and dividends. The latest closing stock price for Atai ...Atai Life Sciences Nv (ATAI) Share Price Forecast. Currently 15 wall-street analysts regularly analyze the financials of Atai Life Sciences Nv on a frequent basis to provide recommendations along with target share price. 15 analysts offering 12-month price forecasts for Atai Life Sciences Nv (ATAI) have a share price target of $12.32.Instagram:https://instagram. stock market going upcompare wealth management firmsforex futures vs spothd nyse Find real-time NEE - Nextera Energy Inc stock quotes, company profile, news and forecasts from CNN Business. forex trade signalsvalue half dollar 1971 23 brokers have issued 1 year price targets for Advanced Micro Devices' shares. Their AMD share price targets range from $80.00 to $200.00. On average, they expect the company's share price to reach $134.77 in the next twelve months. This suggests a possible upside of 11.0% from the stock's current price. iqiyi stocks AI is a growth business. Total spending on AI systems is forecast to reach $97.9 billion in 2023, up from $37.5 billion in 2019. For the five-year period ending in 2023, the AI sector is predicted ...ATAI stock closed at $1.76 and is up $0.10 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ATAI has a strong overall score of 70 meaning the stock holds a better value than 70% of stocks at its current price.Nov 28, 2023 · ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive impairment associated with ...